LATEST ALERTS
A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European Union.
In our latest regulatory snapshot, we look at the current situation in Italy — where taxes and rules have been changing regularly over recent times
CBD-Intel’s report on the regulatory status of CBD in China provides all you need to know about the present legal status of CBD, plus hemp cultivation and much more
CBD-Intel’s regular round-up of regulatory news features items from Canada, New York, Texas, Nevada, Washington State, Italy and Portugal
A batch of CBD oil has been removed from sale by authorities in the Republic of Ireland after it was found to contain THC
The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety
Many US senators seem ready to pass a law allowing financial institutions to work with CBD businesses. That’s if a hearing on the SAFE Banking Act is any indication
The Polish CBD sector is beset by confusing regulation and uneven enforcement – but it does benefit from a reduced rate of VAT, below even that of prescription medical cannabis
The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views
CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium
Sales of water infused with CBD may be held back by doubts over whether the product is effective and also by regulation, recent reporting by CBD-Intel suggests
A tough regulatory regime in Serbia may soon become even tougher as the Commission for Psychoactive Controlled Substances believes CBD should be a scheduled substance
Health Canada has revoked the licence of producer Agrima Botanicals and put a hold on product grown by CannTrust
CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China
While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction
Italy’s Supreme Court has published the reasoning behind its ruling that cannabis products are illegal except for those without psychotropic effects – without adding any clarity
From hummus to suppositories, the UK CBD market is highly fragmented, with over 700 brands available, as CBD-Intel managing director Tim Phillips explains in this presentation given at the Europe CBD Expo in London
Attention in Washington is increasingly focused on CBD, with the US Congress striving to address regulation and the FDA promising policy action soon
CBD has turned Washington upside down, with a legal expert at the conservative Heritage Foundation testifying to Congress on behalf of federalism over states’ rights and free enterprise
Retailers selling CBD wares in Europe are currently facing multiple hurdles, with unclear legislation often leading to roughshod enforcement from local authorities
CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam
An extra helping of regulatory news from CBD-Intel brings you snippets from Argentina, Turkey, Lithuania, Estonia, the US House of Representatives and the state of Iowa
The Texas hemp plan, legalising the cultivation, handling and processing of hemp in the state, became law on 10th June – but would-be manufacturers are still having to wait
Vitafood Insights invited CBD-Intel to participate in one of their podcast sessions to offer a comprehensive understanding of the regulatory landscape of CBD in Europe. CBD is dominating worldwide attention and it is essential for companies looking to launch CBD products in the dietary supplements and functional foods sectors to understand the current regulatory situation and possible future enforcement. Charlotte » Continue Reading.
A German CBD company claims it can’t sell 90% of its stock following action by local authorities, while others are said to be facing charges of involvement in the illegal drug trade
Irish retailers have complained that their small shops have been raided by police and CBD stocks seized – even though they are also expected to pay tax on the products
The Massachusetts Department of Agricultural Resources has confirmed that farmers and processors in the state cannot add CBD to food ingredients
This week’s round-up of regulatory news in the global CBD market includes updates from US federal authorities, Kansas, Massachusetts, New York City, Belgium, Germany and Italy
A group of British MPs is recommending that more trials and research are carried out into cannabis-based medical products (CBMPs), including those containing CBD
The Canadian government has taken a first step towards allowing health products containing CBD – and potentially other cannabinoids – without a prescription
Accurate and consistent CBD dosage will be vital for the industry as edible items become the biggest category of cannabinoid-derived products, experts predict
Smaller CBD stakeholders should not fear the entrance of big business into the market, according to one expert who explains how larger firms can help ease the regulatory path
UK authorities may take no action, and US multi-level marketing company HempWorx will not discipline its British affiliate sellers, over online posts making health claims
A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel, with updates from the US, Canada, EU, Germany, Turkey and the United Nations
In this report we look at the state of Illinois and the new regulations that are set to come in to effect in the near future
US states and tribal territories have no right to stop the transportation of legal hemp that conforms with US Department of Agriculture (USDA) guidelines or was produced under the terms of the 2014 Farm Bill
A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel, with updates from around the US, Belgium, France, Latvia, and Colombia
While cannabis and hemp are controlled substances in South Africa, most finished CBD products are probably legal without a licence – as long as they meet certain conditions
As regulations in China continue to evolve, we look at developments in the third Chinese province to consider new regulations for industrialised hemp
In a potentially serious blow to businesses and users in Sweden, CBD oil containing low levels of THC will be classed as a narcotic following a ruling by the Swedish Supreme Court
A murky legal situation and lack of government direction continue to hold back CBD in the UK and Europe, according to a keynote speaker at next month’s Europe CBD Expo in London
A landmark decision by South Africa’s now former health minister Aaron Motsoledi has legalised lower dosage CBD. But there’s a catch – the ruling only applies until May 2020
The number of French CBD shops reopening after facing legal action continues to rise, with at least seven shopkeepers acquitted of charges against them
The US FDA has confirmed its commitment to creating an alternative route to market for non-pharmaceutical CBD products such as foods and dietary supplements – eventually
A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel
Canada is the centre for the world’s largest cannabis companies and has recently implemented a wide-ranging new regulatory environment for all cannabis products
Some European makers of CBD products have come up with a way to dodge requirements for novel foods – relabelling. But critics warn that could be risky
In this latest look at regulations in Germany, CBD-Intel details how German law and EU rules are governing the CBD market across the country
Continuing CBD-Intel’s ongoing series of concise reports on how CBD is regulated across the US, we consider the state of Pennsylvania
Ben & Jerry’s says it will introduce CBD ice cream to stores throughout the US as soon CBD is legal across the country
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
